Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
+2.45M
-
Total reported value, excl. options
-
$871M
-
Value change
-
+$27.2M
-
Put/Call ratio
-
2.46
-
Number of buys
-
87
-
Number of sells
-
-61
-
Price
-
$17.06
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q1 2024
179 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q1 2024.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
of 96M outstanding shares and own 53.16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.06M shares), STATE STREET CORP (3.74M shares), JENNISON ASSOCIATES LLC (3.42M shares), FRED ALGER MANAGEMENT, LLC (3.11M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.04M shares), T. Rowe Price Investment Management, Inc. (2.47M shares), VANGUARD GROUP INC (2.28M shares), Lynx1 Capital Management LP (2.08M shares), PERCEPTIVE ADVISORS LLC (1.72M shares), and Bain Capital Life Sciences Investors, LLC (1.62M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.